Insight

Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management

Photo from Michael Duruisseaux/X

Apr 11, 2024, 17:17

Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management

Michael Duruisseaux, Medical Director of the Joint Research Unit in Thoracic Oncology of the Hospices Civilians of Lyons, shared on X/Twitter:

“Just out on Lung Cancer Journal!
Based on the experience of two French expert lung cancer teams from Hospices Civils de Lyon and Institut Curie we propose practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management.
Share your opinion!”

Proceed to the article.
Source: Michael Duruisseaux/X

cancer Hospices Civils de Lyon Institut Curie Lung cancer Lung Cancer Journal Michael Duruisseaux OncoDaily Oncology Sotorasib sotorasib-related adverse events

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage